Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT manufacturers
- ABBV-969 Payload
-
- $687.00
-
2026-07-15
- CAS:2857037-70-6
- Purity: 97.00%
- Supply Ability: 10g
|
| | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT Basic information |
| Product Name: | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | | Synonyms: | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT;L-Alaninamide, N-(2-bromoacetyl)-L-valyl-N-[3-[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-14-yl]bicyclo[1.1.1]pent-1-yl]- | | CAS: | 2857037-70-6 | | MF: | C36H38BrN5O9 | | MW: | 764.62 | | EINECS: | | | Product Categories: | | | Mol File: | 2857037-70-6.mol | ![Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT Structure](CAS/20240320/GIF/2857037-70-6.gif) |
| | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT Chemical Properties |
| Boiling point | 1134.5±65.0 °C(predicted) | | density | 1.62±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 11.17±0.20(predicted) | | form | Solid | | color | Light yellow to yellow |
| | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT Usage And Synthesis |
| Uses | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a agent-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make antibody agent conjugate (ADC)[1]. | | References | [1] Phillips AC, et, al. Anti-c-met antibody drug conjugates. WO2022232834A1. |
| | Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT Preparation Products And Raw materials |
|
|
Tag:Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT(2857037-70-6)
Related Product Information
|
|
10-O-Acetyl SN-38
(4S)-9-(Acetyloxy)-10-[(acetyloxy)Methyl]-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]-
Acetamide, 2-amino-N-[[(7S)-7-ethyl-7,8,11,13-tetrahydro-7-hydroxy-8,11-dioxo-10H-1,3-dioxolo[4,5-g]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-14-yl]methyl]-
Glycine, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-9-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-4-yl ester, hydrochloride (1:1)
(4S)-4,8-Diethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
|